{"id":9260,"date":"2013-10-01T06:46:14","date_gmt":"2013-10-01T10:46:14","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=9260"},"modified":"2013-10-03T11:07:31","modified_gmt":"2013-10-03T15:07:31","slug":"abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260","title":{"rendered":"Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/01\/2013 (wallstreetpr) &#8211; After the successful launch of NeuVax drug, Galena Biopahrma Inc (NASDAQ:GALE) is all set to launch Abstral in the US drug market.\u00a0 For the US launch of Abstral, Galena has collected a total amount of $37 million from a share offering. Abstral is a sublingual drug for reducing cancer pain. This efficient drug was developed originally by Orexo Pharmaceuticals but Galena acquired the distribution rights to sell Abstral in the US back in march.\u00a0 Abstral is the first andonly fentanyl tablet that efficiently helps fighting cancer pain in the opioid tolerant patients.<\/p>\n<p style=\"text-align: justify;\">According to many investors point of view, Galena Biopharma might not be able to gain success in the already successful markets for TRIFs. But according to Galena\u2019s CEO Mr. Mark, this point is to be noted that Abstral was the last drug that was approved for distribution in the Europe and it captured a 25% market share.<\/p>\n<p style=\"text-align: justify;\">Let\u2019s see how things are shaping up for Galena after launching Abstral in the US drug market.<\/p>\n<p style=\"text-align: justify;\"><b>About Galena Biopharma Inc<\/b><\/p>\n<p style=\"text-align: justify;\">Formerly RXi Pharmaceuticals Corporation, Galena Biopharma Inc is one of the leading biotechnology companies which primarily focus on discovering, manufacturing and commercializing different therapies that can address unmet medical requirements using targeted biotherapeutics. The firm is now working on the development of cancer therapeutics with the help of peptide based immunotherapy products. The major drug, NeuVaxTM is developed by the company that helps in treating breast cancers and other types of tumors efficiently.<\/p>\n<p style=\"text-align: justify;\">NeuVax is based on peptide immunotherapy and intends to decrease the chances of breast cancer recurrence in the HER2 positive breast cancer patients (both low and intermediate). The phase 2 trial of NeuVax was successfully achieved by Galena and has reached the primary endpoint of DFS (disease free survival).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/01\/2013 (wallstreetpr) &#8211; After the successful launch of NeuVax drug, Galena Biopahrma Inc (NASDAQ:GALE) is all set to launch Abstral in the US [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":9261,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[3124,3122,3123],"stock_ticker":[],"class_list":["post-9260","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-galena-biopharma-inc","tag-galena-biopharma-inc-nasdaqgale","tag-nasdaqgale","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/01\/2013 (wallstreetpr) &#8211; After the successful launch of NeuVax drug, Galena Biopahrma Inc (NASDAQ:GALE) is all set to launch Abstral in the US [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-10-01T10:46:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2013-10-03T15:07:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/23.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US\",\"datePublished\":\"2013-10-01T10:46:14+00:00\",\"dateModified\":\"2013-10-03T15:07:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260\"},\"wordCount\":307,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/23.jpg\",\"keywords\":[\"Galena Biopharma Inc\",\"Galena Biopharma Inc (NASDAQ:GALE)\",\"NASDAQ:GALE\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260\",\"name\":\"Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/23.jpg\",\"datePublished\":\"2013-10-01T10:46:14+00:00\",\"dateModified\":\"2013-10-03T15:07:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/23.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/23.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260","og_locale":"en_US","og_type":"article","og_title":"Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US - Wall Street PR","og_description":"Boston, MA 10\/01\/2013 (wallstreetpr) &#8211; After the successful launch of NeuVax drug, Galena Biopahrma Inc (NASDAQ:GALE) is all set to launch Abstral in the US [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-10-01T10:46:14+00:00","article_modified_time":"2013-10-03T15:07:31+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/23.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US","datePublished":"2013-10-01T10:46:14+00:00","dateModified":"2013-10-03T15:07:31+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260"},"wordCount":307,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/23.jpg","keywords":["Galena Biopharma Inc","Galena Biopharma Inc (NASDAQ:GALE)","NASDAQ:GALE"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260","url":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260","name":"Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/23.jpg","datePublished":"2013-10-01T10:46:14+00:00","dateModified":"2013-10-03T15:07:31+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/23.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/23.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abstral-lunch-by-galena-biopharma-inc-nasdaqgale-in-the-us-9260#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/9260","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=9260"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/9260\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/9261"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=9260"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=9260"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=9260"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=9260"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}